Huron Consulting Group Inc. (HURN) is a Technology stock trading at $159.22 (as of 2026-08-25), with a market capitalization of $2.58B and a trailing P/E of 24.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
I can’t produce a compliant description because the SEC 10‑K “Business” (Item 1) text isn’t provided. Please paste the Item 1 “Business” section for Huron Consulting Group Inc. (or key excerpts), and I’ll generate a 1–2 sentence, ~45-word JSON description based strictly on that text.
Understand Huron Consulting Group Inc.: how it makes money
Huron is a professional-services consultancy serving hospitals, K-12 districts, and enterprise clients with operational, digital, and managed-services work, earning fees on professional hours and recurring contracts. Healthcare is the dominant revenue segment, and the business blends sticky managed-services contracts with project-based consulting that tracks client budgets.
Huron converts roughly 5,900 billable professionals at mid-70s% utilization into fee revenue, while a growing managed-services layer of 2,600+ professionals on recurring contracts shifts the mix toward lower-volatility revenue that slowly lifts the roughly 8% operating margin.
Business quality (Mixed): Mixed: the recurring managed-services layer and 26% ROE give the business quality traits, but an 8% operating margin, $834M of debt, and heavy reliance on healthcare customer budgets keep it tethered to a labor-arbitrage model with limited pricing power.
Valuation: Trades at 25× trailing earnings · $2.6B market cap.
Bull case
Healthcare drives 17.4% growth: Healthcare grew 17.4% in Q2 FY26 across consulting, managed services, advisory, and digital offerings, the fastest pace in the portfolio. This breadth across delivery models supports the company's raised full-year guidance and a stronger backlog and pipeline.
AI widens the addressable book: Management reports most new bookings are now directly or indirectly AI-enabled, expanding Huron's digital capability beyond traditional advisory. This structural shift lets the firm win new work as clients rebuild operations around AI tools, extending the revenue cycle per customer.
RelateCare adds $30M of RBR: The RelateCare acquisition is expected to contribute $30 million of 2026 Revenue Before Reimbursable Expenses and $0.10 of adjusted EPS, showing a repeatable bolt-on strategy that extends the medical-group footprint and supports growth beyond organic demand.
Bear case
Federal cuts squeeze hospital budgets: Healthcare customers face regulatory and reimbursement pressure from substantial federal healthcare spending reductions. Any further drawdown in public funding would compress the very hospital and health-system budgets that drove 17.4% segment growth.
Leverage and cost growth squeeze margin: Debt remains elevated at $834 million, still above the year-end target range, while corporate cost growth from compensation, software, and data-hosting expenses is widening. At an 8% operating margin, there is limited buffer if spending outpaces fee-rate gains.
H2 comps drag headline growth: Commercial growth faces second-half comparisons from prior acquisitions, meaning the 12% YoY revenue growth will look softer in the back half even if absolute bookings hold flat. This flatters the first half and can pressure the multiple in the second.